Publications:

Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk.

Nature Communications

King, Liam B LB; West, Brandyn R BR; Moyer, Crystal L CL; Gilchuk, Pavlo P; Flyak, Andrew A; Ilinykh, Philipp A PA; Bombardi, Robin R; Hui, Sean S; Huang, Kai K; Bukreyev, Alexander A; Crowe, James E JE; Saphire, Erica Ollmann EO

Publication Date: 2019-04-17

Variant appearance in text: HP: S106N

PubMed Link: 30996276

Variant Present in the following documents:

• Main text
• 41467_2019_Article_9732.pdf

View BVdb publication page